CeriBell Quarterly Balance Sheet
NASDAQ: CBLLHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
CeriBell financial position
As of Jun 30, 2026, CeriBell reported total assets of $166.3 million, down 19.9% from a year earlier against total liabilities of $38.0 million. Shareholders' equity stood at $128.3 million, or 77.1% of assets. The company held $32.7 million in cash and equivalents against $20.0 million of debt, a net cash position of $12.7 million.
The current ratio (current assets divided by current liabilities) was 9.18, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.16.
Summary generated from market data by MetaCap's automated system. Methodology
CeriBell balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 32.66M | 45.25M | 40.48M | 23.74M | 40.14M | 153.36M | 194.37M | 14.11M | 24.36M | 32.49M | 34.49M | 45.31M |
| Short-Term Investments | 96.60M | 95.93M | 118.78M | 144.80M | 137.29M | 29.34M | — | — | — | — | — | — |
| Receivables | 15.99M | 15.71M | 15.05M | 12.23M | 12.31M | 11.30M | 10.88M | 9.97M | — | — | 7.96M | — |
| Inventory | 6.74M | 6.90M | 7.29M | 6.02M | 6.00M | 6.55M | 6.94M | 6.91M | — | — | 5.87M | — |
| Total Current Assets | 157.85M | 168.91M | 186.72M | 191.81M | 199.79M | 205.42M | 217.27M | 34.96M | — | — | 51.96M | — |
| Property, Plant & Equipment | 1.76M | 1.93M | 2.03M | 2.06M | 2.10M | 2.13M | 2.31M | 2.27M | — | — | 1.58M | — |
| Total Assets | 166.35M | 178.08M | 195.80M | 199.53M | 207.69M | 213.47M | 225.41M | 47.06M | — | — | 58.92M | — |
| Accounts Payable | 3.19M | 1.98M | 2.84M | 2.18M | 2.44M | 1.37M | 1.14M | 2.78M | — | — | 732.00K | — |
| Total Current Liabilities | 17.20M | 16.18M | 19.19M | 15.17M | 15.01M | 11.83M | 12.99M | 13.09M | — | — | 21.60M | — |
| Long-Term Debt | 19.98M | 19.92M | 19.81M | 19.75M | 19.68M | 19.62M | 19.56M | 19.50M | — | — | — | — |
| Total Liabilities | 38.03M | 37.27M | 40.47M | 35.44M | 35.53M | 32.59M | 34.25M | 35.63M | — | — | 23.76M | — |
| Shareholders' Equity | 128.31M | 140.81M | 155.34M | 164.08M | 172.16M | 180.88M | 191.16M | -135.98M | -127.28M | -119.90M | -112.25M | -105.01M |
| Retained Earnings | -259.36M | -240.09M | -220.36M | -206.83M | -193.36M | -179.72M | -166.94M | -154.37M | — | — | -126.49M | — |
| Total Debt | 19.98M | 19.92M | 19.81M | 19.75M | 19.68M | 19.62M | 19.56M | 19.50M | — | — | — | — |
| Net Cash (Debt) | 109.28M | 121.27M | 139.45M | 148.80M | 157.75M | 163.08M | 174.81M | -5.39M | 24.36M | 32.49M | 34.49M | 45.31M |
| Shares Outstanding | 38.22M | 37.86M | 37.49M | 37.05M | 36.60M | 35.90M | 35.85M | 5.78M | — | — | 5.43M | — |
This table shows 12 quarterly periods of CeriBell's balance sheet, from Q2 2026 back to Q3 2023, across 16 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow CBLL's reporting calendar. What is a balance sheet?